Back to mobile site

Form SCHEDULE 13G/A Q32 Bio Inc. Filed by: Opaleye Management Inc.

May 6, 2026 4:05 PM EDT





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
   Rule 13d-1(b)
   Rule 13d-1(c)
   Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G




Comment for Type of Reporting Person:  Based on 14,629,463 shares of Common Stock outstanding as of March 1, 2026, as reported by Q32 Bio Inc. in its Annual Report on Form 10-K filed with the SEC on March 10, 2026.


SCHEDULE 13G





SCHEDULE 13G



 
Opaleye Management Inc.
 
Signature:/s/ James Silverman
Name/Title:President
Date:05/06/2026
 
Opaleye, L.P.
 
Signature:/s/ James Silverman
Name/Title:General Partner
Date:05/06/2026
 
James Silverman
 
Signature:/s/ James Silverman
Name/Title:Individually
Date:05/06/2026
Exhibit Information

Exhibit 99.1 Joint Filing Agreement by and among the reporting persons

ATTACHMENTS / EXHIBITS

EX-99.1



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings

Related Entities

13G